Celltrion | 068270 - Debt


Celltrion reported KRW160.58B in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Akebia Therapeutics USD 46.51M 7.82M Mar/2025
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Avita Medical AUD 46.05M 1.46M Dec/2025
Celltrion KRW 160.58B 733.3M Mar/2026
Dianthus Therapeutics USD 1.36M 79K Mar/2026
Ionis Pharmaceuticals USD 2.34B 9.5M Mar/2026
IQVIA Holdings USD 15.83B 109M Mar/2026
Moderna USD 1.31B 571M Dec/2025
Organon & Co USD 8.57B 75M Mar/2026
Revvity USD 3.4B 29.2M Dec/2025
Tectonic Therapeutic USD 876K 115K Dec/2024
Viatris USD 14.34B 69.3M Mar/2026
Xeris Pharmaceuticals USD 258.55M 899K Mar/2026